Related Experiment Video

Updated: Jun 26, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

[Azithromycin in the therapy of lower respiratory tract infection in children]

Anna Breborowicz1

  • 1Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Klinika Pneumonologii, Alergologii Dzieciecej i Immunologii Klinicznej III Katedry Pediatrii.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|January 31, 2009
PubMed

Insights

Lower respiratory tract infections (LRTI) pose a significant risk to children, with typical bacteria being common in younger patients. Azithromycin offers a beneficial treatment option, particularly as atypical pathogens become more prevalent in older children.

Area of Science:

  • Pediatric infectious diseases
  • Microbiology
  • Pharmacology

Context:

  • Lower respiratory tract infections (LRTI) represent a major health concern in pediatric populations.
  • Infections are most prevalent in the youngest age groups, primarily caused by typical bacteria.
  • Atypical pathogens are increasingly implicated in LRTI among older pediatric patients.

Purpose:

  • To examine the role of azithromycin in treating pediatric lower respiratory tract infections.
  • To highlight the therapeutic advantages of azithromycin in this demographic.

Summary:

  • LRTI etiology varies with age, with typical bacteria dominating in infants and atypical pathogens rising in significance in older children.
  • Azithromycin is presented as an effective therapeutic agent for pediatric LRTI.
  • The article emphasizes the benefits of azithromycin, considering the changing etiological landscape.

Impact:

  • Provides clinicians with evidence-based information on azithromycin use for pediatric LRTI.
  • Contributes to optimizing antibiotic strategies for respiratory infections in children.
  • Supports informed therapeutic decisions based on pathogen prevalence and drug efficacy.

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.